| Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
| |
| Device | Guardant360 CDx |
| Generic Name | Next generation sequencing oncology panel, somatic or germline variant detection system |
| Applicant | Guardant Health, Inc. 505 Penobscot Dr. Redwood City, CA 94063 |
| PMA Number | P200010 |
| Supplement Number | S005 |
| Date Received | 12/17/2021 |
| Decision Date | 03/16/2022 |
| Product Code |
PQP |
| Advisory Committee |
Pathology |
| Supplement Type | Real-Time Process |
| Supplement Reason | Change Design/Components/Specifications/Material |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approval to use reagent lots interchangeably for Guardant360 CDx Sample Preparation Kit Boxes and a minor software update to accommodate the reagent interchangeability update. |
|
|